Napredna pretraga

Pregled bibliografske jedinice broj: 577477

BMP signalling pathway in experimental inflammatory bowel disease


Marić, Ivana; Smoljan, Ivana; Turk, Tamara; Ćelić, Tanja; Zoričić Cvek, Sanja; Crnčević Orlić, Željka; Bobinac, Dragica
BMP signalling pathway in experimental inflammatory bowel disease // Bone
Atena, Grčka: Elsevier, 2011. str. 238-238 (poster, nije recenziran, sažetak, znanstveni)


Naslov
BMP signalling pathway in experimental inflammatory bowel disease

Autori
Marić, Ivana ; Smoljan, Ivana ; Turk, Tamara ; Ćelić, Tanja ; Zoričić Cvek, Sanja ; Crnčević Orlić, Željka ; Bobinac, Dragica

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Bone / - : Elsevier, 2011, 238-238

Skup
3rd joint meeting of the European Calcified Tissue Society and the International Bone and Mineral Society

Mjesto i datum
Atena, Grčka, 07-12.05.2011

Vrsta sudjelovanja
Poster

Vrsta recenzije
Nije recenziran

Ključne riječi
Koštani morfogenetski protein; upalna bolest crijeva
(Bone morphogenetic protein; inflammatory bowel disease)

Sažetak
Beyond stimulating bone formation, the bone morphogenetic proteins (BMPs) are important in development, inflammation and malignancy of the gut. We have previously shown that BMP7 has a regenerative, anti-inflammatory and anti- proliferative effect on experimental inflammatory bowel disease (IBD) in rat. To further investigate the BMP signaling pathway we monitored the effect of BMP7 therapy on the BMP signaling components in rat colon during different stages of experimentally induced colitis by 2, 4, 6- trinitrobenzene sulfonic acid (TNBS). The results showed increased of BMP2 and -7 expression in the chronic phase of colitis. BMP7 treatment slightly enhanced BMP4, -6 and -7, and suppressed the BMP2 expression. CTGF and noggin expression was elevated in TNBS colitis, and slightly decreased upon BMP7 therapy. BMP receptor I expression was unchanged, while BMP receptor II was increased at day 14 and 30 of TNBS inflammation, and decreased following BMP7 therapy. BMP7 increased Smad1, Smad3 and Smad4. Inhibitory Smads were increased in colitis, but not in rats treated with BMP7. We conclude that BMP signaling is preserved in colon during TNBS-induced colonic inflammation and could be modulated with BMP7, suggesting that IBD is a reversible process with self-recovery features.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE